Owlet, Inc. (OWLT) vs RxSight, Inc. (RXST)
Owlet, Inc. and RxSight, Inc. are both Medical Devices companies. RxSight, Inc. is the larger, with a market value of $196.7M against $148.2M — 1.3× the size. Owlet, Inc. grew revenue faster over the last twelve months: 28.0% against −13.3%. Owlet, Inc. has the higher net margin (−10.7% vs −36.8%) and the higher return on invested capital (−27.6% vs −63.2%). Across the 18 metrics below, Owlet, Inc. leads on 9 and RxSight, Inc. on 9.
Valuation
Profitability
| Metric | OWLT | RXST | Medical Devices median |
|---|---|---|---|
| Gross margin | 54.75% | 77.50% | 56.01% |
| Operating margin | (6.67%) | (43.20%) | (15.03%) |
| Net margin | (10.67%) | (36.80%) | (20.40%) |
| Free cash flow margin | (8.59%) | (21.29%) | (7.24%) |
| Return on equity | 68.03% | (17.35%) | (15.32%) |
| Return on assets | (15.60%) | (14.19%) | (19.72%) |
| Return on invested capital | (27.60%) | (63.16%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack